drug

OCU410ST

1 story · latest Nov 4, 2026

Follow OCU410ST. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Ocugen

Timeline

Ocugen reports Bahamas regulatory progress and MENA license for OCU400 in Q3 update

Nov 4Quarterly updateOCU400 OCU410

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.